- Harrison RW, Aggarwal A, Ou FS, et al. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol. 2013;111(2):178–184. doi:10.1016/j.amjcard.2012.09.015.
- Schwartz BG, Kloner RA. Coronary no reflow. J Mol Cell Cardiol. 2012;52(4):873–882. doi:10.1016/j.yjmcc.2011.06.009.
- Reffelmann T, Hale SL, Li G, Kloner RA. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2002;282(2):H766–H772. doi:10.1152/ajpheart.00767.2001.
- Ndrepepa G, Tiroch K, Keta D, et al. Predictive factors and impact of no-reflow after primary percutaneous coronary intervention in patients with acute myocardial infarction. Circ Cardiovasc Intervent. 2010;3(1):27–33. doi:10.1161/CIRCINTERVENTIONS.109.896225.
- Jaffe R, Dick A, Strauss BH. Prevention and treatment of microvascular obstruction related myocardial injury and coronary no-reflow following percutaneous coronary intervention: a systematic approach. JACC Cardiovasc Interv. 2010;3(7):695–704. doi:10.1016/j.jcin.2010.05.004.
- Aung Naing K, Li L, Su Q, Wu T. Adenosine and verapamil for no-reflow during primary percutaneous coronary intervention in people with acute myocardial infarction. Cochrane Database Syst Rev. 2013;6:CD009503.
- Kelbaek H, Terkelsen CJ, Helqvist S, et al. Randomized comparison of distal protection versus conventional treatment in primary percutaneous coronary intervention: the drug elution and distal protection in ST-elevation myocardial infarction (DEDICATION) trial. J Am Coll Cardiol. 2008;51(9):899–905. doi:10.1016/j.jacc.2007.10.047.
- Stone GW, Webb J, Cox DA, et al. Distal microcirculatory protection during percutaneous coronary intervention in acute ST-segment elevation myocardial infarction: a randomized controlled trial. JAMA. 2005;293(9):1063–1072. doi:10.1001/jama.293.9.1063.
- Ndrepepa G, Tiroch K, Fusaro M, et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol. 2010;55(21):2383–2389. doi: 10.1016/j.jacc.2009.12.054.
- Iwakura K, Ito H, Ikushima M, et al. Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol. 2003;41(1):1–7.
- Capes SE, Hunt D, Malmberg K, et al. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 2000;355(9206):773–778. doi:10.1016/S0140-6736(99)08415-9.
- Nagata Y, Usuda K, Uchiyama A, et al. Characteristics of the pathological images of coronary artery thrombi according to the infarct-related coronary artery in acute myocardial infarction. Circ J. 2004;68(4):308–314.
- Cura FA, L’Allier PL, Kapadia SR, et al; GUSTO IIb and RAPPORT Investigators. Predictors and prognosis of suboptimal coronary blood flow after primary coronary angioplasty in patients with acute myocardial infarction. Am J Cardiol. 2001;88(2):124–128. doi:10.1016/S0002-9149(01)01605-8.
- Mehta RH, Harjai KJ, Cox D, et al. Clinical and angiographic correlates and outcomes of suboptimal coronary flow inpatients with acute myocardial infarction undergoing primary percutaneous coronary intervention. J Am Coll Cardiol. 2003;42(10):1739–1746.
- Parodi G, Valenti R, Carrabba N, et al. Long-term prognostic implications of nonoptimal primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv. 2006;68(1):50–55. doi:10.1002/ccd.20729.
- Sabin P, Koshy AG, Gupta PN, et al. Predictors of no-reflow during primary angioplasty for acute myocardial infarction, from Medical College Hospital, Trivandrum. Indian Heart. 2017;69(Suppl 1):S34–S45. doi: 10.1016/j.ihj.2016.12.012.
- Zhou H, He XY, Zhuang SW, et al. Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention. World J Emerg Med. 2014;5(2):96–102. doi:10.5847/wjem.j.issn.1920-8642.2014.02.003.
Predictors and prognosis of no-reflow during primary percutaneous coronary intervention
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.